Skip to main content

Treatment for late-stage prostate cancer patients: getting closer to a solution

4 Apr 16



Press and Communications Officer
Tel.+34 93 40 37255

The European Research Council (ERC) has written an ERC Story about Xavier Salvatella, ICREA researcher and leader of the Laboratory of Mollecular Biophysics.

Treatment for late -stage prostate cancer patients: getting closer to a solution

Professor Salvatella is an ERC grantee, whose research is focused in looking for new prostatic cancer therapies that would bypass the resistance that some pacients develop over time. In particular, he studies the folding of the protein androgen receptor as a model for studying the disease.

Xavier Salvatella also starred in a video of IRB Barcelona's series Meet Our Scientists, which has the aim to promote IRB Barcelona scientists, attract talent, and disseminate biomedicine.







About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).